drugset / Trial / NCT07040917
A Study of CAR-T Cells in Subjects With Autoimmune Diseases
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety and efficacy of CAR-T cell therapy in Subjects with autoimmune diseases.
Timeline
- Start
- 2025-09-30
- Primary completion
- 2027-11-30
- Completion
- 2028-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CAR-T cell | Cell therapy | — | — |